Ghana’s government has recognized that obtaining COVID-19 vaccines to vaccinate a portion of the population is problematic.
It claims that vaccine shortages is not unique to Ghana, but also to other nations throughout the world, particularly in Africa.
Following the scarcity of COVID-19 vaccinations, the administration has committed to do everything possible to procure the vaccinations for the second phase of the country’s immunization campaign.
Health officials said they are now in touch with other European nations and are looking into other viable methods for obtaining vaccinations for the nation.
“What is happening to Ghana is a global issue. So what we are doing is that, this government is engaging directly with other European countries who have stock of AstraZeneca and are not deploying them that much. So we will continue to explore”, a member of Ghana’s COVID-19 response team, Dr. Bernard Okoe Boye said on The Point of View on Citi TV, on Monday night.
“What is going on in Ghana is a worldwide problem. So what we’re doing is interacting directly with other European nations that have AstraZeneca stock but aren’t using it as much as they could. So we’ll keep looking,” Dr. Bernard Okoe Boye, a member of Ghana’s COVID-19 response team, said on Citi TV’s The Point of View on Monday night.
He, on the other hand, was unable to provide timetables.
According to him, “it will be difficult to speak and state the specific date because, with this Africa platform that we are using and the direct Russia -Government engagement people are talking about, they tell us that it will take six or 12 months before the vaccines will come and remember in a year, a lot can happen.”
Ghana received 650,000 doses of AstraZeneca vaccines from the COVAX facility, as well as 50,000 doses from the Indian government and 165,000 doses from MTN, for its mass immunization campaign.
Since then, the Government has struggled to get additional vaccinations in order to reach its goal of immunizing 20 million people.
However, it has been revealed that the government is utilizing intermediaries to get some of Russia’s Sputnik-V vaccinations, at a cost of US$ 19 instead of the initial manufacturing price of US$ 10.
Source: CITINEWSROOM
